다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Pharmaceutical Inc (RARE) 뉴스

RARE

Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/08	05:30	GlobeNewswire Inc.	Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/03	05:00	GlobeNewswire Inc.	Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/05/01	05:00	GlobeNewswire Inc.	Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/30	21:00	GlobeNewswire Inc.	Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/26	05:30	GlobeNewswire Inc.	Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/20	05:30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/15	20:00	GlobeNewswire Inc.	Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/13	05:22	GlobeNewswire Inc.	Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/04/12	21:00	GlobeNewswire Inc.	Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/23	05:00	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/03/06	10:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/28	06:30	GlobeNewswire Inc.	Ultragenyx to Participate at Investor Conferences in March	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/24	06:05	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/22	07:03	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/16	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/16	06:01	GlobeNewswire Inc.	Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/09	06:00	GlobeNewswire Inc.	Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/06	22:00	GlobeNewswire Inc.	Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Heparan Sulfate Exposure in Cerebrospinal Fluid Correlated with Improved Long-term Cognitive Function in Patients with Sanfilippo Syndrome Type A (MPS IIIA)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/02/06	06:05	GlobeNewswire Inc.	Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treatment of Angelman Syndrome	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/01/26	06:05	GlobeNewswire Inc.	Ultragenyx Announces Completion of Dosing Across Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/01/20	06:00	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/01/08	21:00	GlobeNewswire Inc.	Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/01/08	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc

검색 관련기사 보기:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 다음 >>

Societe Generale Effekten

Bnp Paribas Issuance Bv ...

I.DE.MS.GER.CL.CH.ESG EO

Compass Therapeutics

Liquid Staked ETH

France Soir Groupe

Lyxor Asset Management L...

Vlaamse Gemeenschap 1.00...

Nuveen Texas Quality Mun...

Platinum Group Metals

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관